Targeting Angiogenesis in Head and Neck Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|7|643-649

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.7, 2007-11, pp. : 643-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 650-665

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-12 ,pp. : 691-710

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials

By Beckham Thomas H   Elojeimy Saeed   Cheng Joseph C   Turner Lorianne S   Hoffman Stanley R   Norris James S   Liu Xiang  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 529-539

Informa Healthcare

Access to resources Recommend Favorite

Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-01 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 637-651

Bentham Science Publishers

Access to resources Recommend Favorite